1. EDUCATIONAL BACKGROUND

• 2001 – 2005: Engineer degree in Mechanical Engineering, Nong Lam University Ho Chi Minh City, Vietnam. 

• 2008-2010: Master in Microsystems and Nanoengineering, National Tsing Hua University, Taiwan.   

• 2015-2019: Doctor of Philosophy (Biomedical Engineering), National University of Singapore (NUS), Singapore.

2. WORK EXPERIENCE

• 04/2019-08/2019: Scientist, Institute of Medical Devices, VinSmart Company, Ha Noi, Vietnam

• 2019-2021: Postdoctoral Research Associate, University of Cambridge, United Kingdom

• 04/2021-12/2024: Research Assistant Professor & PI, The Chinese University of Hong Kong, Hong Kong

• 03/2024-04/2024: Visiting Scholar, Otoinnovation Lab, Professor Peter Santa Maria MD PhD

• 01/2025–2028: Adjunct Assistant Professor, The Chinese University of Hong Kong, Hong Kong

• 11/2025-now: Researcher, Institute for Computational Science and Artificial Intelligence, Van Lang University, Vietnam

3. RESEARCH INTEREST

• AI in Biomedical Engineering

• AI & LLMs for Scientific Discovery

• AI Agents for Healthcare: Otolaryngology

• AI LLM Agents for Microfluidics

• AI Tutors, AI Chatbots

4. RESEARCH GRANTS

No	Project name	Levels of Organization,Name of Organization	Role (Pricinpal investigator or member)	Duration	Results
1	Microfluidics, 3D Bioprinting & AI for Precision Cancer Therapy, Neurodegenerative Diseases and Sustainability	BME Grant, 150,000 HKD (~20,000 USD)	Principal Investigator	2022-2024	Completed
2	Propagation-On-Chip: Unravelling propagation of misfolding proteins in high throughput physiological neurodegenerative disease models	Engineering Grant, Faculty of Engineering, CUHK, 2022-2023, 150,000 HKD (~20,000 USD)	Principal Investigator	2022-2023	Completed
3	Propagation-On-Chip (POC): Unravelling the Propagation of Misfolded Proteins in High Throughput Human Physiological Neurodegenerative Disease Models	GRF (The Research Grants Council (RGC)), No. 14211223, ~ 900,000, HKD (~120,000USD)	Principal Investigator	2022-2026	Ongoing
4	iHOPE: Artificial Intelligence-Driven Decoding of Phenotypic Cancer Heterogeneity to Predict Response to Drug Combinations	Provectus Therapeutics, 500,000 HKD/ Year (3 years) (~192,000USD)	Member	2024-2027	Ongoing
5	iHOPE: Artificial Intelligence-Driven Decoding of Phenotypic Cancer Heterogeneity to Predict Response to Drug Combinations	Provectus Therapeutics, 6,000,000 HKD/ 4 Year (~767,000USD)	Member	2024-2028	Ongoing

5. TEACHING

• 2006-2008: Lecturer, Nong Lam University Ho Chi Minh City, Vietnam

• 2016: Certificate, Teaching assistant, National University of Singapore, Singapore

• 2015-2018: Teaching Assistant, National University of Singapore, Singapore

• Fall 2021: Guest Lecturer ([BME core course) & Lecturer (BME elective course)

• Spring 2022: Guest Lecturer, The Chinese University of Hong Kong, Hong Kong

6. ADVISING & SUPERVISION

• Director Dinh Lab at Department of Biomedical Engineering, CUHK: 1 PhD Student (Starting August, 2022), 1 Postdoc, 2 Research Assistants, 2 FYP students

• Graduated: 6 Bachelors of Engineering (in Biomedical Engineering, CUHK) students by final year projects (FYP) (Graduated 2021, 2022), 1 Bachelors of Engineering (in Biomedical Engineering, NUS) students by final year projects (FYP)

7. STARTUP EXPERIENCE

• Co-Founder & CSO at Provectus Therapeutics, a spinout company working on AI and Microfluidics for Precision Cancer Therapy https://provectustherapeutics.com/

• Provectus Therapeutics has secured ~ 1 million USD, plan 5M USD in seed round

• Consultant: Xampla Ltd, Cambridge, UK

8. AWARDS

• 2001-2005: Scholarship from Nong Lam University HCM city, Vietnam for excellent student

• 2005: Honor, Silver Medal, Nong Lam University, HCM city, Vietnam

• 2008-2010: Full Scholarship for Master Nano/Microsystem of National Tsing Hua University, Taiwan

• 2015-2019: Full Scholarship (24,000 S$/year) for Ph.D study of National University of Singapore

• 2021: Win Pitch Prize for Launching a Startup Company, CUHK PI Center, 30,000 HKD (~4000 USD)

• 2023: YDC Wards for Provectus Therapeutics, 30,000 HKD (~4000 USD) Hong Kong Science Park

9. EDITORSHIPS

• Member of Biomedical Engineering Society (BMES, USA)

• Member of Royal Chemistry Society (RSC), UK

10. SHORT BIOGRAPHY

Dinh Ngoc Duy, Ph.D., MRSC, is an accomplished researcher and academic currently serving as an Adjunct Assistant Professor (2025–2028) and previously a Research Assistant Professor & Principal Investigator (2021–2024) at the Department of Biomedical Engineering, The Chinese University of Hong Kong (CUHK),. He earned his Ph.D. in Biomedical Engineering from the National University of Singapore (NUS) in 2019. His professional journey includes significant international experience, having worked as a Postdoctoral Research Associate at the University of Cambridge, UK, and as a scientist at research institutes in Germany and industry in Vietnam. Dr. Duys career path is like building a bridge between different worlds: he combines the precision of mechanical engineering with the complexity of biology, then uses Artificial Intelligence as a modern architect to design better healthcare solutions.